tadalafil has been researched along with Pulmonary Embolism in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, M; Gall, H; Grünig, E; Halank, M; Mielniczuk, L; Orozco-Levi, M; Tanabe, N; Vachiéry, JL; Vogtländer, K | 1 |
| Tanabe, N | 1 |
| Chen, HC; Chuang, SH; Wang, CS; Wang, CY | 1 |
3 other study(ies) available for tadalafil and Pulmonary Embolism
| Article | Year |
|---|---|
Real-World Switching to Riociguat: Management and Practicalities in Patients with PAH and CTEPH.
Topics: Aged; Aged, 80 and over; Chronic Disease; Drug Substitution; Enzyme Activators; Female; Humans; Hypertension, Pulmonary; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Pulmonary Embolism; Pyrazoles; Pyrimidines; Retrospective Studies; Sildenafil Citrate; Tadalafil | 2018 |
Can results from a Japanese pulmonary hypertension registry have an impact on Western guidelines?
Topics: Angioplasty, Balloon; Cyclic Nucleotide Phosphodiesterases, Type 1; Drug Therapy, Combination; Endarterectomy; Epoprostenol; Genome-Wide Association Study; Hemodynamics; Humans; Hypertension, Pulmonary; Japan; Molecular Targeted Therapy; Phenylpropionates; Phosphodiesterase 5 Inhibitors; Practice Guidelines as Topic; Pulmonary Embolism; Pyridazines; Randomized Controlled Trials as Topic; Registries; Sildenafil Citrate; Tadalafil | 2018 |
Pulmonary embolism after tadalafil ingestion.
Topics: Carbolines; Erectile Dysfunction; Humans; Male; Middle Aged; Phosphodiesterase Inhibitors; Protein C; Pulmonary Embolism; Tadalafil | 2008 |